GMO Pepabo, Inc.

As of June 30, 2026, GMO Pepabo, Inc. carries a market capitalization of 8.50B, placing it among publicly traded companies globally. Its enterprise value stands at 6.83B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

GMO Pepabo, Inc.'s next confirmed earnings release is scheduled for November 9, 2026.

As of June 30, 2026, GMO Pepabo, Inc. has 5.16M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, GMO Pepabo, Inc. maintains a current ratio of 1.15, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, GMO Pepabo, Inc.'s stock has gained approximately 27.88% over the past 52 weeks. The 50-day moving average sits at 2,498.40, while the 200-day moving average is 2,042.15.

As of June 30, 2026, GMO Pepabo, Inc. holds 2.07B in cash and equivalents against 400.00M in total debt, resulting in a net debt position of -1.67B. Total book value stands at 3.30B, with working capital of 1.16B providing operational flexibility.

GMO Pepabo, Inc.'s most recent stock split took place on March 27, 2019 with a 1:2 split ratio.